2 terminated, 1 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 2, Completed 1 |
Follow Immunodeficiency Syndrome: new trials by email Literature Review of Immunodeficiency Syndrome trials Research Report on Immunodeficiency Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer Cyclophosphamide, Fludarabine Phosphate, Laboratory Biomarker Analysis - Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission | Phase 2 | Terminated | Roswell Park Cancer Institute | 31 | 2017-12-07 | 2025-07-04 |
| Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by a Donor Stem Cell Transplant in Treating Patients With Immunodeficiency or Other Nonmalignant Inherited Disorders Alemtuzumab, Allogeneic Bone Marrow Transplantation, Allogeneic Hematopoietic Stem Cell Transplantation - Immunodeficiency Syndrome, Non-Cancer Diagnosis | Phase 2 | Completed | Fred Hutchinson Cancer Center | 29 | 2006-06-01 | 2020-02-17 |
| Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant and Cyclophosphamide, Mycophenolate Mofetil, Tacrolimus, and Sirolimus in Treating Patients With Primary Immunodeficiency Disorders or Noncancerous Inherited Disorders Allogeneic Bone Marrow Transplantation, Cyclophosphamide, Fludarabine Phosphate - Immunodeficiency Syndrome, Severe Aplastic Anemia | Phase 2 | Terminated | Fred Hutchinson Cancer Center | 14 | 2006-05-24 | 2021-01-26 |
Immunologic Deficiency Syndromes (3) · Anemia, Aplastic (2) · Anemia, Diamond-Blackfan (1) · Anemia, Sickle Cell (1) · Congenital amegakaryocytic thrombocytopenia (1) · Genetic Diseases, Inborn (1) · Granulomatous Disease, Chronic (1) · Hemoglobinuria, Paroxysmal (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Leukemia, Myeloid, Accelerated Phase (1) · Leukemia, Myeloid, Acute (1) · Leukemia, Myeloid, Chronic-Phase (1) · Leukemia, Myelomonocytic, Chronic (1) · Lymphoma, B-Cell (1)
Immune System Diseases (3) · Anemia (2) · Bone Marrow Diseases (2) · Bone Marrow Failure Disorders (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Anemia, Hemolytic (1) · Anemia, Hemolytic, Congenital (1) · Anemia, Hypoplastic, Congenital (1) · Blood Coagulation Disorders (1) · Blood Coagulation Disorders, Inherited (1) · Blood Platelet Disorders (1) · Blood Protein Disorders (1) · Bone Marrow Neoplasms (1)
Whole-Body Irradiation (3) · fludarabine phosphate (3) · Cyclophosphamide (2) · Mycophenolic Acid (2) · Alemtuzumab (1) · Cyclosporine (1) · Cyclosporins (1) · Peripheral Blood Stem Cell Transplantation (1) · Sirolimus (1) · Tacrolimus (1)
Fred Hutchinson Cancer Center (2) · Roswell Park Cancer Institute (1)
United States (3)
Kanwaldeep Mallhi (1) · Lauri Burroughs (1) · Philip McCarthy, MD (1)
P30CA015704 (2), P01HL122173 (1)